Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Related Posts
TSMC, the Chip Giant, Is to Spend $100 Billion in U.S. Over the Next 4 Years
The investment plan, announced at the White House, was made as the Trump administration pushes to bring chip making back…
Slowing Electric Vehicle Sales Will Cost G.M. $1.6 Billion
General Motors said it would lower its earnings by that amount to mainly reflect the drop in the value of…
Trump Tariffs Add to Apple’s Long-Standing Innovation Woes
Even before the threat of President Trump’s tariffs, there were questions about the company’s inability to make good on new…